GSK plc
GSK37.430USD
-0.070-0.19%
收盤 04/25, 16:00（美東）報價延遲15分鐘
77.58B總市值
23.79本益比TTM
關於 GSK plc 公司
GSK plc 是一家全球性生物製藥公司。該公司的部門包括商業運營和研發。該公司爲卵巢癌、子宮內膜癌和多發性骨髓瘤等患者開發抗癌藥物。其產品領域包括疫苗、特種藥物和普通藥物。該公司還專注於解決呼吸系統和炎症患者尚未滿足的治療需求。其疫苗組合包括 20 多種疫苗，可幫助保護人們免受一系列疾病和感染，包括腦膜炎、帶狀皰疹和流感等。其特種藥物部門還致力於開發用於呼吸系統疾病和艾滋病毒的藥物。其普通藥物包括用於哮喘和慢性阻塞性肺病的吸入藥物、抗生素和用於皮膚病的藥物。該公司正在推進慢性乙型肝炎和脂肪肝以及肝病以外其他治療領域的寡核苷酸療法。
公司簡介
公司代碼GSK
公司名稱GSK plc
上市日期May 22, 1972
成立日期1999
CEOMs. Deborah Waterhouse
員工數量68629
證券類型Ordinary Share
年結日May 22
公司地址980 Great West Road
城市BRENTFORD
上市交易所London Stock Exchange
國家United Kingdom
郵編TW8 9GS
電話442080475000
網址https://www.gsk.com/
公司代碼GSK
上市日期May 22, 1972
成立日期1999
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
暫無數據
名稱
名稱/職務
職務
持股
持股變動
暫無數據
收入明細
單位: USD更新時間: 4月6日 週日
單位: USD更新時間: 4月6日 週日
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
Respiratory
9.22B
22.99%
HIV
9.06B
22.59%
Shingles
4.30B
10.72%
Established Vaccines
4.27B
10.64%
Immuno-inflammation
4.21B
10.51%
Other
9.04B
22.54%
地區USD
名稱
營收
佔比
US
20.93B
52.22%
Rest of world
18.25B
45.53%
UK
904.53M
2.26%
業務
地區
業務USD
名稱
營收
佔比
Respiratory
9.22B
22.99%
HIV
9.06B
22.59%
Shingles
4.30B
10.72%
Established Vaccines
4.27B
10.64%
Immuno-inflammation
4.21B
10.51%
Other
9.04B
22.54%
股東統計
更新時間: 2月21日 週五
更新時間: 2月21日 週五
持股股東
股東類型
持股股東
股東統計
佔比
Dodge & Cox
3.33%
Fidelity Management & Research Company LLC
2.13%
PRIMECAP Management Company
1.23%
Fisher Investments
0.92%
JTC Employer Solutions Trusteee Ltd
0.74%
Other
91.66%
持股股東
股東統計
佔比
Dodge & Cox
3.33%
Fidelity Management & Research Company LLC
2.13%
PRIMECAP Management Company
1.23%
Fisher Investments
0.92%
JTC Employer Solutions Trusteee Ltd
0.74%
Other
91.66%
股東類型
股東統計
佔比
Investment Advisor
8.78%
Investment Advisor/Hedge Fund
6.23%
Hedge Fund
0.93%
Research Firm
0.71%
Bank and Trust
0.09%
Individual Investor
0.06%
Pension Fund
0.06%
Insurance Company
0.06%
Family Office
0.02%
Other
83.07%
機構持股
更新時間: 1月19日 週日
更新時間: 1月19日 週日
報告期間
機構數
持股數
持股佔比
持股變動
2025Q1
1444
354.89M
17.21%
+26.92M
2024Q4
1481
355.06M
17.14%
+27.38M
2024Q3
1472
319.97M
15.44%
-30.07M
2024Q2
1585
322.06M
15.54%
-29.11M
2024Q1
1617
318.91M
15.39%
-23.52M
2023Q4
1614
299.81M
14.57%
-35.71M
2023Q3
1570
293.92M
14.35%
-37.46M
2023Q2
1545
286.58M
13.99%
-41.88M
2023Q1
1546
281.08M
13.72%
-55.01M
2022Q4
1546
286.90M
13.32%
-22.15M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Dodge & Cox
68.44M
3.32%
+353.75K
+0.52%
Dec 31, 2024
Fidelity Management & Research Company LLC
43.77M
2.12%
+18.14M
+70.76%
Dec 31, 2024
PRIMECAP Management Company
25.26M
1.22%
+10.41M
+70.07%
Dec 31, 2024
Fisher Investments
18.84M
0.91%
+259.87K
+1.40%
Dec 31, 2024
JTC Employer Solutions Trusteee Ltd
20.28M
0.98%
-202.40K
-0.99%
Dec 31, 2024
Fidelity Institutional Asset Management
9.05M
0.44%
+5.68M
+168.17%
Dec 31, 2024
Goldman Sachs Asset Management, L.P.
8.85M
0.43%
+1.77M
+25.04%
Dec 31, 2024
T. Rowe Price International Ltd
7.57M
0.37%
+35.11K
+0.47%
Dec 31, 2024
State Street Global Advisors (US)
7.03M
0.34%
+247.17K
+3.65%
Dec 31, 2024
UBS Financial Services, Inc.
6.34M
0.31%
+5.69M
+871.38%
Dec 31, 2024
查看更多
持股ETF
更新時間: 4月6日 週日
更新時間: 4月6日 週日
機構名稱
佔比
The Opal International Dividend Income ETF
6.71%
VanEck Pharmaceutical ETF
4.7%
Keating Active ETF
3.52%
Brandes International ETF
3.27%
Sound Equity Dividend Income ETF
3.17%
Altrius Global Dividend ETF
1.9%
Pacer Global Cash Cows Dividend ETF
1.87%
USCF Dividend Income Fund
1.59%
Fidelity Blue Chip Value ETF
1.4%
Fidelity Women's Leadership ETF
1.08%
查看更多
The Opal International Dividend Income ETF
佔比6.71%
VanEck Pharmaceutical ETF
佔比4.7%
Keating Active ETF
佔比3.52%
Brandes International ETF
佔比3.27%
Sound Equity Dividend Income ETF
佔比3.17%
Altrius Global Dividend ETF
佔比1.9%
Pacer Global Cash Cows Dividend ETF
佔比1.87%
USCF Dividend Income Fund
佔比1.59%
Fidelity Blue Chip Value ETF
佔比1.4%
Fidelity Women's Leadership ETF
佔比1.08%
分紅派息
近5年累計派現
20.79B
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
Feb 05, 2025
GSK.NB Approximate interim Cash Dividend of gross USD 0.400652 paid on Apr 10, 2025 going ex on Feb 21, 2025
Feb 21, 2025
Apr 10, 2025
Feb 21, 2025
Oct 30, 2024
GSK.NB Final Cash Dividend of gross USD 0.376892 paid on Jan 09, 2025 going ex on Nov 15, 2024
Nov 15, 2024
Jan 09, 2025
Nov 15, 2024
Jul 31, 2024
GSK.NB Interim Cash Dividend of gross USD 0.392813 paid on Oct 10, 2024 going ex on Aug 16, 2024
Aug 16, 2024
Oct 10, 2024
Aug 16, 2024
May 01, 2024
GSK.NB Interim Cash Dividend of gross USD 0.384301 paid on Jul 11, 2024 going ex on May 16, 2024
May 17, 2024
Jul 11, 2024
May 16, 2024
Feb 01, 2024
GSK.NB Interim Cash Dividend of gross USD 0.404885 paid on Apr 11, 2024 going ex on Feb 22, 2024
Feb 23, 2024
Apr 11, 2024
Feb 22, 2024
Nov 01, 2023
GSK.NB Final Cash Dividend of gross USD 0.356356 paid on Jan 11, 2024 going ex on Nov 16, 2023
Nov 17, 2023
Jan 11, 2024
Nov 16, 2023
Jul 26, 2023
GSK.NB Interim Cash Dividend of gross USD 0.343532 paid on Oct 12, 2023 going ex on Aug 17, 2023
Aug 18, 2023
Oct 12, 2023
Aug 17, 2023
Apr 26, 2023
GSK.NB Interim Cash Dividend of gross USD 0.360944 paid on Jul 13, 2023 going ex on May 18, 2023
May 19, 2023
Jul 13, 2023
May 18, 2023
Feb 01, 2023
GSK.NB Interim Cash Dividend of gross USD 0.341883 paid on Apr 13, 2023 going ex on Feb 23, 2023
Feb 24, 2023
Apr 13, 2023
Feb 23, 2023
Nov 02, 2022
GSK.NB Final Cash Dividend of gross USD 0.334785 paid on Jan 12, 2023 going ex on Nov 17, 2022
Nov 18, 2022
Jan 12, 2023
Nov 17, 2022
查看更多
拆合股
公告日期
類型
比率
Jun 24, 2022
Merger
5<4
Jun 24, 2022
Merger
5<4
Jun 24, 2022
Merger
5<4
Jun 24, 2022
Merger
5<4
公告日期
類型
比率
Jun 24, 2022
Merger
5<4
Jun 24, 2022
Merger
5<4
Jun 24, 2022
Merger
5<4
Jun 24, 2022
Merger
5<4